News

27/03/2025
Research, innovation and global success: EsoBiotec takes off also thanks to Italian science
From innovation to value creation: the crucial role played by the research performed at OSR and Fondazione Telethon in the development of innovative technologies, has been confirmed by the success of EsoBiotec SA. As part of its design, their therapeutic asset incorporates an engineered viral surface component developed by Luigi Naldini and Alessio Cantore at the San Raffaele Telethon Institute for Cell and Gene Therapy (SR-TIGET), facilitated by the strategic efforts of the Business Development Division at San Raffaele Hospital.
MORE
25/03/2025
Three research projects from San Raffaele Hospital for the treatment of tumors and chronic inflammatory diseases have received proof-of-concept fundings from EXTEND
The IRCCS San Raffaele Hospital continues his translational mission thanks to new proof-of-concept fundings for three research projects with the potential of generating startups. The fundings are granted by EXTEND, the National Centre for Biotechnological Technology Transfer by CDP Venture Capital with the contribution of Evotec and Angelini Ventures. In the past, the hospital had already obtained EXTEND fundings to finance research that leads to concrete therapies aimed at improving patient’s lives.
MORE
24/03/2025
World Tuberculosis Day: between therapeutic approaches and diagnostic methodologies
March 24th is World Tuberculosis Day which aims at raising public awareness of a disease that is still widespread all over the world and figures among the top ten causes of death worldwide.
MORE
13/03/2025
A very common ciliopathy: polycystic kidney
Polycystic kidney disease or polycystic kidney is a pathology that affects the kidneys, the organs that filter the blood, purifying it of impurities, produce urine, keep blood pressure under control and, in general, maintain the water-salt balance of the body.
MORE